Isthmus Partners’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-109,104
| Closed | -$8.55M | – | 202 |
|
|
2023
Q3 | $8.55M | Buy |
109,104
+495
| +0.5% | +$41.4K | 1.23% | 38 |
|
|
2023
Q2 | $9.57M | Buy |
108,609
+985
| +0.9% | +$84.8K | 1.3% | 35 |
|
|
2023
Q1 | $8.68M | Buy |
107,624
+7,108
| +7% | +$579K | 1.22% | 39 |
|
|
2022
Q4 | $7.81M | Buy |
100,516
+18,818
| +23% | +$1.53M | 1.17% | 41 |
|
|
2022
Q3 | $6.6M | Buy |
81,698
+1,190
| +1% | +$107K | 1.14% | 42 |
|
|
2022
Q2 | $7.23M | Buy |
80,508
+3,329
| +4% | +$337K | 1.35% | 37 |
|
|
2022
Q1 | $8.56M | Buy |
77,179
+4,713
| +7% | +$498K | 1.41% | 38 |
|
|
2021
Q4 | $7.5M | Buy |
72,466
+3,648
| +5% | +$422K | 1.26% | 37 |
|
|
2021
Q3 | $8.63M | Buy |
68,818
+605
| +0.9% | +$78.3K | 1.56% | 27 |
|
|
2021
Q2 | $8.47M | Sell |
68,213
-980
| -1% | -$123K | 1.49% | 34 |
|
|
2021
Q1 | $8.17M | Buy |
69,193
+37
| +0.1% | +$4.34K | 1.5% | 37 |
|
|
2020
Q4 | $8.1M | Buy |
69,156
+353
| +0.5% | +$38.9K | 1.64% | 29 |
|
|
2020
Q3 | $7.15M | Buy |
68,803
+589
| +0.9% | +$59.2K | 1.67% | 29 |
|
|
2020
Q2 | $6.25M | Buy |
68,214
+740
| +1% | +$71K | 1.54% | 32 |
|
|
2020
Q1 | $6.08M | Sell |
67,474
-13,902
| -17% | -$1.48M | 1.87% | 27 |
|
|
2019
Q4 | $9.23M | Sell |
81,376
-1,495
| -2% | -$164K | 2.1% | 8 |
|
|
2019
Q3 | $9M | Sell |
82,871
-2,335
| -3% | -$244K | 2.13% | 7 |
|
|
2019
Q2 | $8.3M | Buy |
+85,206
| New | +$7.78M | 1.98% | 11 |
|
|
2019
Q1 | – | Sell |
-81,938
| Closed | -$7.45M | – | 170 |
|
|
2018
Q4 | $7.45M | Buy |
81,938
+1,662
| +2% | +$155K | 2.24% | 13 |
|
|
2018
Q3 | $7.9M | Sell |
80,276
-311
| -0.4% | -$28.8K | 1.99% | 17 |
|
|
2018
Q2 | $6.9M | Sell |
80,587
-68
| -0.1% | -$5.68K | 1.8% | 25 |
|
|
2018
Q1 | $6.47M | Buy |
80,655
+1,071
| +1% | +$88.3K | 1.75% | 32 |
|
|
2017
Q4 | $6.43M | Buy |
79,584
+448
| +0.6% | +$35.9K | 1.75% | 30 |
|
|
2017
Q3 | $6.15M | Sell |
79,136
-148
| -0.2% | -$12.3K | 1.73% | 31 |
|
|
2017
Q2 | $7.04M | Sell |
79,284
-2,251
| -3% | -$190K | 2.06% | 9 |
|
|
2017
Q1 | $6.57M | Buy |
81,535
+269
| +0.3% | +$21K | 1.93% | 20 |
|
|
2016
Q4 | $5.79M | Buy |
81,266
+2,296
| +3% | +$180K | 1.75% | 29 |
|
|
2016
Q3 | $6.61M | Sell |
78,970
-3,555
| -4% | -$310K | 2.09% | 11 |
|
|
2016
Q2 | $7.16M | Sell |
82,525
-2,419
| -3% | -$196K | 2.36% | 4 |
|
|
2016
Q1 | $6.37M | Sell |
84,944
-3,154
| -4% | -$238K | 2.13% | 11 |
|
|
2015
Q4 | $6.78M | Sell |
88,098
-1,957
| -2% | -$147K | 2.36% | 6 |
|
|
2015
Q3 | $6.03M | Sell |
90,055
-766
| -0.8% | -$56.4K | 2.21% | 8 |
|
|
2015
Q2 | $6.73M | Buy |
+90,821
| New | +$6.94M | 2.22% | 8 |
|
|
2015
Q1 | – | Sell |
-90,317
| Closed | -$6.52M | – | 267 |
|
|
2014
Q4 | $6.52M | Buy |
+90,317
| New | +$6.27M | 2.22% | 10 |
|
Other funds holding MDT
Isthmus Partners's MDT Position: Q4 2023 in Review
Isthmus Partners sold out of Medtronic (MDT) in Q4 2023, closing a stake of 109,104 shares — an estimated $8.55M sold.
Isthmus Partners first reported a position in MDT in Q4 2014 and held it in 34 quarters. The position peaked at $9.57M in Q2 2023. 2,074 funds tracked by Wall St. Rank hold MDT as of Q4 2023.
- Isthmus Partners reported no remaining Medtronic position as of Q4 2023 after selling out during the quarter.
- Isthmus Partners sold 109,104 Medtronic shares in Q4 2023, an estimated $8.55M.
- Isthmus Partners first reported a position in Medtronic in Q4 2014 and held it in 34 quarters.
- Isthmus Partners's Medtronic position peaked at $9.57M in Q2 2023.
- 2,074 funds tracked by Wall St. Rank held Medtronic as of Q4 2023.
Based on Isthmus Partners's 13F filing for Q4 2023, filed 12 Feb 2024.